Real-World Application of Anti-β-Amyloid Monoclonal Antibodies: Untangling Eligibility
- PMID: 37586880
- DOI: 10.1212/WNL.0000000000207873
Real-World Application of Anti-β-Amyloid Monoclonal Antibodies: Untangling Eligibility
Comment on
-
Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging.Neurology. 2023 Nov 7;101(19):e1837-e1849. doi: 10.1212/WNL.0000000000207770. Epub 2023 Aug 16. Neurology. 2023. PMID: 37586881 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical